IL-6 levels in migraine patients receiving topiramate

Pain Practice

Volumn 9, Issue 5, 2009, Pages 375-379

  Koçer, Abdulkadir ^a   Memişoĝullari, Ramazan ^a   Domaç, Fusun Mayda ^b   Ilhan, Atilla ^c   Koçer, Emel ^a   Okuyucu, Şefika ^a   Özdemir, Burcu ^a   Yüksel, Hatice ^a  

^a DUZCE UNIVERSITY   (Turkey)

^b GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^c FATIH UNIVERSITY   (Turkey)

Author keywords

Inflammation; Interleukin 6; Migraine; Pain; Topiramate

Indexed keywords

INTERLEUKIN 6; TOPIRAMATE;

ADULT; ARTICLE; DRUG EFFICACY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PAIN ASSESSMENT; PROPHYLAXIS; PROTEIN BLOOD LEVEL; VISUAL ANALOG SCALE;

ADULT; FEMALE; FRUCTOSE; HUMANS; IMMUNOENZYME TECHNIQUES; INTERLEUKIN-6; MALE; MIDDLE AGED; MIGRAINE DISORDERS; NEUROPROTECTIVE AGENTS; STATISTICS AS TOPIC;

EID: 77951962837     PISSN: 15307085     EISSN: 15332500     Source Type: Journal    
DOI: 10.1111/j.1533-2500.2009.00301.x     Document Type: Article

References (34)

1. Kronfol Z, Remick DG. Cytokines and the brain: implications for clinical psychiatry. Am J Psychiatry 2000, 157:683-694.
2. Gruol DL, Nelson TE. Physiological and pathological roles of interleukin-6 in the central nervous system. Mol Neurobiol 1997, 15:307-339.
3. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumor necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107:660-664.
4. Oka T, Oka K, Hosoi M, Hori T. Intracerebroventricular injection of interleukin-6 induces thermal hyperalgesia. Brain Res 1995, 692:123-128.
5. Ramer MS, Murphy PG, Richardson PM, Bisby MA. Spinal nerve lesion induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice. Pain 1997, 78:115-121.
6. Xu XJ, Hao JX, Andell-Jonsson S, Poli V, Bartfai T, Wisenfeld-Hallin Z. Nociceptive responses in interleukin-6 deficient mice to peripheral inflammation and peripheral nerve section. Cytokine 1997, 9:1028-1033.
7. Reuter U, Sanchez del Rio M, Moskowitz MA. Experimental models of migraine. Funct Neurol 2000, 15:9-18.
8. Goadsby PJ, Edvinsson L. The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33:48-56.
9. Goadsby PJ, Edvinsson L, Ekman R. Vasoactive peptide release in the extracerebral circulation of humans during migraine headache. Ann Neurol 1990, 28:183-187.
10. Buzzi MG, Moskowitz MA. The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater. Br J Pharmacol 1990, 99:202-206.
11. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH. The pivotal role of tumour necrosis factor alpha in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107:660-664.
12. Junger H, Sorkin LS. Nociceptive and inflammatory effects of subcutaneous TNF alpha. Pain 2000, 85:145-151.
13. Watkins LR, Goehler LE, Relton J, Brewer MT, Maier SF. Mechanisms of tumor necrosis factor-alpha (TNF-alpha) hyperalgesia. Brain Res 1995, 692:244-250.
14. Rainero I, Grimaldi LM, Salani G, Valfre W, Rivoiro C, Savi L, Pinessi L. Association between the tumor necrosis factor-alpha -308 G/A gene polymorphism and migraine. Neurology 2004, 62:141-143.
15. Christopherson K, Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells 2001, 19:388-396.
16. Modi S, Dionne M. Medications for migraine prophylaxis. Am Fam Physician 2006, 73:72-80.
17. Silberstein SD, Neto W, Schmitt J, Jacobs D. Topiramate in migraine prevention: results of a large controlled trial. Arch Neurol 2004, 61:490-495.
18. Brandes JL, Saper JR, Diamond M, Couch JR, Lewis DW, Schmitt J. Topiramate for migraine prevention: a randomized controlled trial. JAMA 2004, 291:965-973.
19. The International Classification of Headache Disorders. 2nd Edition. Cephalalgia 2004, 24:8-160. Headache Classification Subcommittee of the International Headache Society
20. Benveniste EN. Inflammatory cytokines within the central nervous system: sources, function, and mechanism of action. Am J Physiol 1992, 263:1-16.
21. Theoharides TC, Cochrane DE. Critical role of mast cells in inflammatory diseases and the effect of acute stress. J Neuroimmunol 2004, 146:1-12.
22. Christopherson K, Hromas R. Chemokine regulation of normal and pathologic immune responses. Stem Cells 2001, 19:388-396.
23. Kemper RHA, Meijler WJ, Korf J, Ter Horst GJ. Migraine and function of the immune system: a meta-analysis of clinical literature published between 1966 and 1999. Cephalalgia 2001, 21:549-557.
24. Empl M, Sostak P, Riedel M, Schwarz M, Muller N, Forderreuther S, Straube A. Decreased sTNF-RI in migraine patients? Cephalalgia 2003, 23:55-58.
25. Cuesta MC, Quintero L, Pons H, Suarez-Roca H. Substance P and calcitonin gene-related peptide increase IL-1 beta, IL-6 and TNF alpha secretion from human peripheral blood mononuclear cells. Neurochem Int 2002, 40:301-306.
26. Levite M. Neuropeptides, by direct interaction with T cells, induce cytokine secretion and break the commitment to a distinct T helper phenotype. Proc Natl Acad Sci USA 1998, 95:12544-12549.
27. Perini F, D'Andrea G, Galloni E, Pignatelli F, Billo G, Alba S, Bussone G, Toso V. Plasma cytokine levels in migraineurs and controls. Headache 2005, 45:926-939.
28. Mueller L, Gupta AK, Stein TP. Deficiency of tumor necrosis factor alpha in a subclass of menstrual migraineurs. Headache 2001, 41:129-137.
29. van Hilten JJ, Ferrari MM, Van der Meer JWM, Gijsman HJ, Looij BJ. Plasma interleukin-1, tumour necrosis factor and hypothalamic-pituitary-adrenal axis responses during migraine attacks. Cephalalgia 1991, 11:65-67.
30. Rainero I, Salani G, Valfrè W, Savi L, Rivoiro C, Ferrero M, Pinessi L, Grimaldi LM. Absence of linkage between the interleukin-6 gene (-174 G/C) polymorphism and migraine. Neurosci Lett 2003, 343:155-158.
31. Fidan I, Yuksel S, Ymir T, Irkec C, Aksakal FN. The importance of cytokines, chemokines and nitric oxide in pathophysiology of migraine. J Neuroimmunol 2006, 171:184-188.
32. Sarchielli P, Floridi A, Mancini ML, Rossi C, Coppola F, Baldi A, Pini LA, Calabresi P. NF-kappaB activity and iNOS expression in monocytes from internal jugular blood of migraine without aura patients during attacks. Cephalalgia 2006, 26:1071-1079.
33. Sarchielli P, Alberti A, Baldi A, Coppola F, Rossi C, Pierguidi L, Floridi A, Calabresi P. Proinflammatory cytokines, adhesion molecules, and lymphocyte integrin expression in the internal jugular blood of migraine patients without aura assessed ictally. Headache 2006, 46:200-207.
34. Engstrom G, Hedblad B, Rosvall M, Janzon L, Lindgarde F. Occupation, marital status, and low-grade inflammation: mutual confounding or independent cardiovascular risk factors? Arterioscler Thromb Vasc Biol 2006, 26:643.